Full-Time

IT Applications Manager

AP LIS Implementation & Support

Updated on 9/10/2026

Sonic Healthcare USA

Sonic Healthcare USA

51-200 employees

Laboratory and pathology testing services

No salary listed

Dallas, TX, USA

In Person

Category
IT Operations (1)
Required Skills
HIPAA

Get referred to Sonic Healthcare USA

See people who can refer or advise you

Requirements
  • 6–10+ years of experience in LIS systems, healthcare IT, clinical applications, or laboratory operations technology.
  • 2–5+ years of leadership, team management, supervisory, or major workstream leadership experience.
  • Strong understanding of Anatomic Pathology LIS workflows, including accessioning, histology, cytology, pathology reporting, case tracking, IHC/special stains, and digital pathology coordination.
  • Experience leading or supporting medium to large-scale implementations, upgrades, go-live events, command center operations, hypercare, production support, and stabilization activities.
  • Working knowledge of application support models, incident management, problem management, issue escalation, testing, validation, and transition-to-support processes.
  • Knowledge of regulatory and compliance requirements in healthcare or laboratory environments, including CLIA, CAP, HIPAA, 21 CFR Part 11, and validation/documentation expectations.
  • Ability to coordinate across technical, operational, vendor, compliance, billing, and leadership stakeholders.
  • Strong communication, prioritization, coaching, analytical thinking, troubleshooting, decision-making, and operational leadership skills.
Responsibilities
  • Lead implementation delivery and production support operations for AP LIS applications and workflows.
  • Oversee Application Support (L1/L2) and Implementation (L3/L4) teams, including workload prioritization, resource planning, support coverage, and service performance.
  • Own end-to-end implementation execution, including project planning, workflow readiness, testing coordination, validation support, cutover planning, go-live command center operations, hypercare, and transition to steady-state support.
  • Ensure Level 1 and Level 2 support processes provide timely ticket intake, triage, user communication, incident management, routine issue resolution, and escalation readiness.
  • Coordinate Level 3 and Level 4 escalation pathways with Implementation analysts, LIS Configuration & Build, Integration, Infrastructure, Middleware, vendors, and other technical teams.
  • Partner with LIS Configuration & Build teams to coordinate required configuration components, including rules, test catalogs, provider/clinic setup, workflow configuration, validation evidence, and release readiness.
  • Ensure LIS solutions align to AP workflows including accessioning, grossing, histology, microtomy, IHC/special stains, cytology, molecular/AP ancillary workflows, pathology reporting, case tracking, and digital pathology coordination where applicable.
  • Coordinate integration and dependency management across digital pathology systems, EMR/result delivery platforms, billing systems, label/printer workflows, and downstream reporting tools.
  • Monitor operational performance, issue trends, root cause findings, defect patterns, support backlog, go-live readiness risks, and stabilization outcomes.
  • Drive continuous improvement in support processes, implementation methodology, documentation quality, escalation models, and knowledge management.
  • Collaborate with Operations, QA/Compliance, Billing/RCM, IT Infrastructure, Integration, vendors, and enterprise leadership to resolve issues and ensure successful delivery.
  • Ensure compliance with CLIA, CAP, HIPAA, 21 CFR Part 11, internal change control, validation, release management, and documentation expectations.
  • Provide leadership, coaching, performance management, role clarity, capacity planning, and professional development for team members.
  • Communicate status, risks, dependencies, decisions, and operational impacts to IT Laboratory Operations leadership and cross-functional stakeholders.

Sonic Healthcare USA provides laboratory testing and professional pathology services across the United States as part of Sonic Healthcare Limited, one of the world’s largest medical diagnostics groups. It operates through nine divisions and around eight thousand employees, following a federated model that puts medical leadership at the local level to ensure high-quality, community-based testing for doctors and patients. Its tests cover core diagnostic laboratory services and pathology expertise used by medical practitioners, hospitals, and community health services. The company aims to deliver precise, timely results and strong clinical partnerships to improve patient care by offering comprehensive laboratory testing and pathology support while maintaining close ties to local healthcare providers.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Austin, Texas

Founded

2014

Get referred to Sonic Healthcare USA

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BCAL and Sonic advanced BreastestPlus validation in Austin on 2026-05-28.
  • Cairo Diagnostics expands oncology testing nationwide and supports liquid biopsy ambitions.
  • FY2026 U.S. underlying organic growth reached 2% after Alabama and AP restructuring.

What critics are saying

  • Veracyte's patent case against Sonic Healthcare USA remains active in Texas federal court.
  • The 2025 Alabama payer loss and nine-practice AP rationalization prove reimbursement fragility.
  • Jan. 1, 2027 PAMA cuts and Change Healthcare debtor write-downs pressure margins.

What makes Sonic Healthcare USA unique

  • Federated model gives local pathologists decision authority inside a national U.S. network.
  • CLIA labs in Austin, Dallas, and New York support rapid LDT validation.
  • Acquired Cairo Diagnostics on 2025-08-22, adding integrated hematology-oncology reporting.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Company News

Daily Dispatch
May 28th, 2026
BCAL Diagnostics and Sonic Healthcare advance validation of BreastestPlus Version 2 for US market.

BCAL Diagnostics and Sonic Healthcare advance validation of BreastestPlus Version 2 for US market. BCAL Diagnostics (ASX:BDX) has taken a step toward bringing its flagship blood test to the United States by signing a Validation Agreement with Sonic Healthcare USA. The agreement calls for BreastestPlus Version 2 to be transferred to Sonic's CLIA-certified Sonic Reference Laboratory in Austin, Texas, where the assay will be optimised and validated for the US market. The move follows BCAL's aim to establish BreastestPlus Version 2 as a Laboratory Developed Test in the US, a pathway the company describes as the fastest and most efficient route for US market entry. The US breast cancer diagnostics market is large and growing, with more than 40 million mammograms performed annually and roughly 376,000 new breast cancer cases each year. BCAL said successful validation at Sonic's facility would represent a key milestone on that pathway and could lead to commercial licensing discussions between the two organisations. BCAL said it also continues to collect clinical samples from patients across the US in collaboration with leading breast cancer specialists. Those samples will support BCAL's Clinical Outcomes studies, which the company says are necessary for regulatory and reimbursement submissions. Shane Ryan, Chief Executive Officer, BCAL, said, "This Validation Agreement with Sonic Healthcare USA is an important milestone for BCAL Diagnostics and our US commercialisation strategy. Sonic's CLIA-certified laboratory infrastructure and deep expertise in clinical diagnostics provide the right environment to validate BreastestPlus(TM) Version 2. What excites me most is what this brings together - two highly capable teams, united by a shared purpose of delivering better diagnostic solutions for women at scale. We look forward to progressing through the validation process and advancing towards commercial deployment in the world's largest breast cancer diagnostics market." Dr Mohamed Salama, Chief Medical Officer, Sonic Healthcare USA, said, "Sonic Healthcare USA is committed to advancing access to innovative diagnostic solutions that make a real difference to patients. The validation of BreastestPlus(TM) Version 2 at our CLIA-certified Sonic Reference Laboratory in Austin, Texas, reflects that commitment, and we look forward to assessing its performance through a rigorous validation process." The financial terms of the Validation Agreement were not disclosed.

Newswise
Aug 22nd, 2025
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic's National Hematology Oncology Testing Capabilities

Sonic Healthcare USA, Inc. announces acquisition of Cairo Diagnostics LLC to expand Sonic's national hematology oncology testing capabilities.

PR Newswire
Aug 22nd, 2025
Sonic Healthcare Acquires Cairo Diagnostics

Sonic Healthcare USA, Inc. has acquired Cairo Diagnostics LLC to enhance its national hematology oncology testing capabilities. Founded by Dr. Sherif Ibrahim, Cairo is known for its integrated oncology testing approach, combining various diagnostic methods to provide comprehensive reports. This acquisition aims to expand Sonic's reach and improve service to oncologists nationwide, offering faster and more complete diagnostic solutions.

The West Australian
Mar 20th, 2024
Sonic Healthcare beefs up Swiss presence with $202m purchase of laboratory group Dr Risch

Sonic Healthcare will beef up its presence in Switzerland with the purchase of laboratory group Dr Risch for 117 million Swiss francs ($202m).

Business News Australia
Apr 27th, 2023
Sonic announces $611m in German acquisitions in April

Australias largest pathology company has today announced its second German acquisition this month, with binding agreements signed to purchase Medical Laboratori